ScholarIQanswers from OpenAlex & ORCID
Jan Budczies
ResearcherPublications, citations & collaboration network
Jan Budczies is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jan Budczies have?
ScholarIQindexed works
Jan Budczies has 434 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jan Budczies have?
ScholarIQcitation count
Jan Budczies has 24,173 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jan Budczies?
ScholarIQh-index
Jan Budczies has an h-index of 62 in OpenAlex.
What is the i10-index of Jan Budczies?
ScholarIQi10-index
Jan Budczies has an i10-index of 156 in OpenAlex.
What is the ORCID of Jan Budczies?
ScholarIQorcid
The ORCID for Jan Budczies is on the source record.
What is the OpenAlex record for Jan Budczies?
ScholarIQopenalex
The OpenAlex for Jan Budczies is on the source record.
What are the most-cited papers on Jan Budczies?
ScholarIQmost cited works
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
Carsten Denkert, Gϋnter von Minckwitz, Silvia Darb‐Esfahani, Bianca Lederer, Barbara Ingold Heppner, Karsten E. Weber, Jan Budczies, Jens Huober, Frederick Klauschen, Jenny Furlanetto, Wolfgang Schmitt, Jens‐Uwe Blohmer, Thomas Karn, Berit M. Pfitzner, Sherko Kümmel, Knut Engels, Andreas Schneeweiß, Arndt Hartmann, Aurelia Noske, Peter A. Fasching, Christian Jackisch, Marion van Mackelenbergh, Hans‐Peter Sinn, Christian Schem, Claus Hanusch, Michael Untch, Sibylle Loibl
Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors
Dan Sha, Zhaohui Jin, Jan Budczies, Klaus Kluck, Albrecht Stenzinger, Frank A. Sinicrope
The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival
Arne Warth, Thomas Muley, Michael Meister, Albrecht Stenzinger, Michael Thomas, Peter Schirmacher, Philipp A. Schnabel, Jan Budczies, Hans Hoffmann, Wilko Weichert
Implementing tumor mutational burden (TMB) analysis in routine diagnostics—a primer for molecular pathologists and clinicians
Michael Allgäuer, Jan Budczies, Petros Christopoulos, Volker Endris, Amelie Lier, Eugen Rempel, Anna‐Lena Volckmar, Martina Kirchner, Moritz von Winterfeld, Jonas Leichsenring, Olaf Neumann, Stefan Fröhling, Roland Penzel, Michael Thomas, Peter Schirmacher, Albrecht Stenzinger
Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project
Diana Merino Vega, Laura M. Yee, Lisa M. McShane, P. Mickey Williams, L. Chen, Tomas Vilimas, David Fabrizio, Vincent Funari, Justin Y. Newberg, L.K. Bruce, S.-J. Chen, Jonathan Baden, J. Carl Barrett, Philip Beer, Matthew G. Butler, Jen‐Hao Cheng, Jeffrey Conroy, Dinesh Cyanam, Kenneth R. Eyring, E. Garcia, G. Green, Vivi Raundahl Gregersen, Matthew D. Hellmann, Laurel A. Keefer, Laura Lasiter, Alexander J. Lazar, M.-C. Li, Laura E. MacConaill, Kristen Meier, Hestia Mellert, Sarabjot Pabla, Aparna Pallavajjalla, Gary A. Pestano, Roberto Salgado, Raed Samara, Ethan S. Sokol, Phillip Stafford, Jan Budczies, Albrecht Stenzinger, W Tom, Kenneth C. Valkenburg, X.Z. Wang, Victor Weigman, Mingchao Xie, Qiqi Xie, Ahmet Zehir, Chen Zhao, Yiqiang Zhao, Mark Stewart, Jeff Allen